Table 3 Enrichment analysis of pathways between both seropositive groups and the seronegative group. Significant entries with Benjamini score equal or smaller than 0.05 are shown
From: Expression analysis of lung miRNAs responding to ovine VM virus infection by RNA-seq
Pathway | Seropositive asymptomatic-Seronegative | Lesions-Seronegative | ||
|---|---|---|---|---|
Fold enrichment | Benjamini | Fold enrichment | Benjamini | |
oas04151:PI3K-Akt signaling pathway | 2.327 | 2,51E-04 | 1.868 | 0.004 |
oas04152:AMPK signaling pathway | 2.831 | 0.024 | 2.411 | 0.022 |
oas05202:Transcriptional misregulation in cancer | – | – | 2.111 | 0.024 |
oas05161:Hepatitis B | 2.542 | 0.027 | 2.134 | 0.047 |
oas04012:ErbB signaling pathway | 3.296 | 0.034 | 2.519 | 0.048 |
oas05200:Pathways in cancer | – | – | 1.595 | 0.049 |
oas04512:ECM-receptor interaction | 3.186 | 0.024 | 2.435 | 0.050 |
oas04510:Focal adhesion | 2.232 | 0.029 | – | – |
oas05215:Prostate cancer | 3.296 | 0.034 | – | – |
oas04360:Axon guidance | 2.643 | 0.034 | – | – |
oas04014:Ras signaling pathway | 2.112 | 0.038 | – | – |
oas05206:MicroRNAs in cancer | 2.190 | 0.050 | – | – |